Abstract A88: Age differences in demographic predictors of head and neck cancer survival

Abstract

Background: The United States population is aging, and cancer is the second most common cause of death in the elderly. Head and neck squamous cell carcinoma (HNSCC) incidence is increasing and contributes 2.2% of all cancer mortality. HNSCC research often excludes elderly patients due to disqualifying comorbidities, similar to many cancer sites. These patients also may not receive adequate therapy due to age despite evidence of equal survival after controlling for comorbidities. Beyond oncologic variables, demographic factors have been shown to impact HNSCC survival, including age, socioeconomic status, race, sex, poverty, insurance, and marriage. Whether these associations are maintained in elderly patients is unknown. This study aims to compare demographic predictors of HNSCC survival between age cohorts. Methods: Adult patients with squamous cell carcinoma of mucosal head and neck sites were selected from the Surveillance, Epidemiology and End Result database from 2004 to 2013. Patients were excluded with previous malignancies or missing data for follow-up, marital status, and surgical treatment. Demographic and tumor data were collected, including site, stage, treatment, age, race, sex, insurance, and median county-level income. Patients were divided into three age cohorts: younger (18-49 years), middle (50-74 years), and older (>75 years). Cohorts were compared with two-tailed chi-squared and ANOVA tests as appropriate with p < 0.05 considered significant. Previously identified predictors of HNSCC survival were assessed in each cohort using multivariate Fine and Gray competing risk models controlled for oncologic variables. Subdistribution hazard ratios (sHR) with 95% confidence intervals (CI) are reported. Sensitivity analyses were performed by (1) excluding inadequately treated patients, (2) removing adjuvant therapies from the model, and (3) varying the cutoff between age cohorts. Inadequate treatment was considered less than 1 modality for stage I-II or less than 2 modalities for stage III-IV. Results: The study cohort consisted of 69,098 patients with a majority white (75.4%), male (76.7%), married (55.2%), and insured (56.3%). The median age at diagnosis was 61.7 years with 14.3% below 50 years and 15.3% 75 years or above. Compared to the young and middle-aged cohorts, the older cohort was significantly more often female (35% vs 25.1 and 20.4%), white (78.7% vs 69.4 and 75.9%), and insured (63.5% vs 46.5% and 56.8%), but received adequate treatment less often (72.0% vs 86.3% and 82.7%) (p < 0.001 for all). In the survival models, several demographic factors showed different effects on cancer survival between age cohorts. Male sex was associated with lower mortality in the older group (sHR 0.92, CI 0.85-1.00), but not in other cohorts. In the young and middle-aged cohort, Black race was associated with increased mortality (sHR 1.43 and 1.23, CI 1.27-1.60 and 1.17-1.30, respectively), but this is not found in the older cohort (sHR 1.07, CI 0.94-1.22). In all cohorts, single marital status was associated with higher mortality, but the effect was greatest in the younger cohort (sHR 1.52, CI 1.37-1.68) and least in the oldest cohort (sHR 1.14, CI 1.01-1.28). These effects were preserved in the sensitivity analyses and with varying the age cutoff between middle and older cohorts as low as 65 years. Conclusion: A substantial proportion of HNSCC patients are elderly. These patients are less often treated with adequate curative therapy and differ demographically from their younger peers. Uniquely in the older HNSCC patients, female sex is a risk factor for cancer mortality, while the impact of race and marital status was reduced compared to the younger cohorts. While future research investigates the mechanisms by which demographics affect survival, the differences between age cohorts must be considered. Citation Format: Sean T. Massa, Lauren Cass, Sai Challapalli, Zisansha Zahirsha, Matt Simpson, Nosayaba Osazuwa-Peters, Gregory Ward. Age differences in demographic predictors of head and neck cancer survival [abstract]. In: Proceedings of the Tenth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2017 Sep 25-28; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2018;27(7 Suppl):Abstract nr A88.

Complications, Mortality, and Functional Decline in Patients 80 Years or Older Undergoing Major Head and Neck Ablation and Reconstruction

“…The incidence of newly diagnosed head and neck squamous cell carcinoma in the elderly is also expected to increase by more than 60% by the year 2030 . Cancer is the second most common cause of death in the elderly and similar to other cancer sites, head and neck cancer research often excludes the elderly due to disqualifying comorbidities …”

“…3 Cancer is the second most common cause of death in the elderly and similar to other cancer sites, head and neck cancer research often excludes the elderly due to disqualifying comorbidities. 4 Elderly patients with head and neck cancer are often considered poor candidates for multimodality therapy owing to impaired functional status and preexisting comorbidities. Thus, elderly patients are less likely to receive standard of care treatment compared with their younger counterparts.…”